Requires Adobe Acrobat ReaderRequires Adobe Acrobat Reader| Malignancies by Type | Year of Transplant | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | |
| Total # of Post-Tx Malignancies | 1,046 | 1,100 | 1,016 | 897 | 825 | 754 | 621 | 477 | 263 | 93 |
| Squamous/Basal Cell Carcinoma | 569 | 562 | 510 | 470 | 414 | 389 | 287 | 240 | 135 | 48 |
| Melanoma | 30 | 37 | 26 | 29 | 30 | 21 | 16 | 17 | 12 | 6 |
| Kaposi Sarcoma | 7 | 10 | 8 | 2 | 5 | 6 | 3 | 5 | 2 | 1 |
| Central Nervous System | 8 | 9 | 12 | 9 | 4 | 5 | 6 | 4 | 2 | 1 |
| Genito-Urinary (1) | 154 | 163 | 142 | 137 | 122 | 113 | 105 | 67 | 39 | 14 |
| Gastro-Intestinal (2) | 95 | 77 | 71 | 55 | 54 | 53 | 49 | 43 | 19 | 8 |
| Primary Hepatic Tumor | 4 | 11 | 9 | 8 | 4 | 10 | 6 | 8 | 9 | 4 |
| Metastatic Hepatic Tumor | 9 | 13 | 19 | 14 | 12 | 8 | 10 | 8 | 4 | 1 |
| Larynx/Bronchi/Lung | 75 | 82 | 93 | 73 | 75 | 68 | 68 | 39 | 13 | 2 |
| Breast/Thyroid | 43 | 58 | 55 | 48 | 57 | 38 | 35 | 21 | 16 | 5 |
| Leukemia | 4 | 5 | 9 | 9 | 4 | 9 | 5 | 3 | 1 | 1 |
| Sarcoma (3) | 2 | 3 | 5 | - | 4 | 3 | 1 | 1 | 2 | - |
| Other | 36 | 55 | 47 | 34 | 25 | 29 | 25 | 16 | 9 | 2 |
| Unknown | 10 | 15 | 10 | 9 | 15 | 2 | 5 | 5 | - | - |
| Squamous/Basal Cell Carcinoma | 54.4% | 51.1% | 50.2% | 52.4% | 50.2% | 51.6% | 46.2% | 50.3% | 51.3% | 51.6% |
| Melanoma | 2.9% | 3.4% | 2.6% | 3.2% | 3.6% | 2.8% | 2.6% | 3.6% | 4.6% | 6.5% |
| Kaposi Sarcoma | 0.7% | 0.9% | 0.8% | 0.2% | 0.6% | 0.8% | 0.5% | 1.0% | 0.8% | 1.1% |
| Central Nervous System | 0.8% | 0.8% | 1.2% | 1.0% | 0.5% | 0.7% | 1.0% | 0.8% | 0.8% | 1.1% |
| Genito-Urinary (1) | 14.7% | 14.8% | 14.0% | 15.3% | 14.8% | 15.0% | 16.9% | 14.0% | 14.8% | 15.1% |
| Gastro-Intestinal (2) | 9.1% | 7.0% | 7.0% | 6.1% | 6.5% | 7.0% | 7.9% | 9.0% | 7.2% | 8.6% |
| Primary Hepatic Tumor | 0.4% | 1.0% | 0.9% | 0.9% | 0.5% | 1.3% | 1.0% | 1.7% | 3.4% | 4.3% |
| Metastatic Hepatic Tumor | 0.9% | 1.2% | 1.9% | 1.6% | 1.5% | 1.1% | 1.6% | 1.7% | 1.5% | 1.1% |
| Larynx/Bronchi/Lung | 7.2% | 7.5% | 9.2% | 8.1% | 9.1% | 9.0% | 11.0% | 8.2% | 4.9% | 2.2% |
| Breast/Thyroid | 4.1% | 5.3% | 5.4% | 5.4% | 6.9% | 5.0% | 5.6% | 4.4% | 6.1% | 5.4% |
| Leukemia | 0.4% | 0.5% | 0.9% | 1.0% | 0.5% | 1.2% | 0.8% | 0.6% | 0.4% | 1.1% |
| Sarcoma (3) | 0.2% | 0.3% | 0.5% | - | 0.5% | 0.4% | 0.2% | 0.2% | 0.8% | - |
| Other | 3.4% | 5.0% | 4.6% | 3.8% | 3.0% | 3.8% | 4.0% | 3.4% | 3.4% | 2.2% |
| Unknown | 1.0% | 1.4% | 1.0% | 1.0% | 1.8% | 0.3% | 0.8% | 1.0% | - | - |
| Total # of Patients | 718 | 738 | 717 | 661 | 612 | 575 | 490 | 382 | 216 | 78 |
Requires Adobe Acrobat Reader